| Literature DB >> 29321506 |
Lisa Pfeiffer1, Joachim Ruther1, John Hofferberth2, Johannes Stökl3,4.
Abstract
According to current evolutionary theory, insect pheromones can originate from extant precursor compounds being selected for information transfer. This is exemplified by females of the parasitoid wasp Leptopilina heterotoma whose defensive secretion consisting mainly of (-)-iridomyrmecin has evolved secondary functions as cue to avoid other females during host search and as female sex pheromone. To promote our understanding of pheromone evolution from defensive secretions we studied the chemical ecology of Leptopilina clavipes. We show here that L. clavipes also produces a defensive secretion that contains (-)-iridomyrmecin as major component and that females use it to detect and avoid host patches occupied by other females. However, the female sex pheromone of L. clavipes consists solely of cuticular hydrocarbons (CHCs) and males did not respond to female CHCs if presented in combination with the defensive secretion containing (-)-iridomyrmecin. This is in contrast to other species of Leptopilina, in which the iridoid compounds have no inhibiting effect or even function as sex pheromone triggering courtship behaviour. This indicates that Leptopilina species differ in the cost-benefit ratio for males searching for females, which might explain the strong divergence in the composition of the sex pheromone in the genus.Entities:
Mesh:
Substances:
Year: 2018 PMID: 29321506 PMCID: PMC5762818 DOI: 10.1038/s41598-017-18376-w
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Compounds identified in the extracts of females and males of Leptopilina clavipes. KRI = Kovats retention index on a non-polar (DPX-5) GC column. Diagn. Ion = diagnostic ions used in the identification of the compound. Diag. Ion DMDS = diagnostic ions of unsaturated compounds after derivatisation with DMDS. The percentage of compounds is based on the total peak area of all identified peaks. tr = trace amounts. Numbers of compounds correspond to Fig. 1.
| No. | Compound | KRI | Diagn. Ions | Diagn. Ions DMDS | Females Mean % | Females SD % | Males Mean % | Males SD % |
|---|---|---|---|---|---|---|---|---|
| 1 | Iridodial 1 | 1313 | 168 (M+), 111, 135 | 1.07 | 0.52 | 0.13 | 0.13 | |
| 2 | Iridodial 2 | 1317 | 168 (M+), 109, 135 | 0.75 | 0.37 | 0.12 | 0.11 | |
| 3 | unknown, identical to P3 in[ | 1322 | 67, 81, 109, 152 | 0.51 | 0.23 | 0.24 | 0.14 | |
| 4 | unknown, identical to P4 in[ | 1365 | 67, 81, 109 | 0.38 | 0.28 | 0.22 | 0.28 | |
| 5 | (−)-iridomyrmecin | 1467 | 168 (M+), 95, 109 | 14.81 | 5.65 | 2.89 | 1.31 | |
| 6 | (+)-isoiridomyrmecin | 1479 | 168 (M+), 95, 109 | 0.23 | 0.09 | tr | ||
| 7 | Heptadecane | 1700 | 240 (M+) | 0.19 | 0.07 | 0.04 | 0.02 | |
| 8 | Octadecane | 1800 | 254 (M+) | 0.06 | 0.03 | 0.04 | 0.02 | |
| 9 | Nonadecane | 1900 | 268 (M+) | 0.10 | 0.04 | 0.05 | 0.03 | |
| 10 | Heneicosane | 2000 | 282 (M+) | 0.10 | 0.03 | 0.07 | 0.03 | |
| 11 | Eicosane | 2100 | 296 (M+) | 0.08 | 0.02 | 0.06 | 0.05 | |
| 12 | Docosane | 2200 | 310 (M+) | 0.03 | 0.01 | 0.03 | 0.04 | |
| 13 | 4-methyl docosane | 2262 | 324 (M+), 309 (M-15), 281 | 0.36 | 0.32 | 0.06 | 0.06 | |
| 14 | 9-tricosene | 2275 | 322 (M+), 97 | 416 (M+), 173, 243 | 0.30 | 0.23 | 0.04 | 0.03 |
| 15 | 7-tricosene | 2282 | 322 (M+), 97 | 416 (M+), 145, 271 | 0.09 | 0.07 | ||
| 16 | Tricosane | 2300 | 324 (M+) | 0.10 | 0.06 | 0.05 | 0.05 | |
| 17 | Tetracosane | 2400 | 338 (M+) | 0.05 | 0.03 | |||
| 18 | 4-methyl tetracosane | 2463 | 352 (M+), 337 (M-15), 309 | 1.20 | 0.83 | 0.74 | 0.51 | |
| 19 | x,x-pentacosadiene[ | 2473 | 348 (M+), 96 | 0.23 | 0.16 | 0.12 | 0.05 | |
| 20 | 9-pentacosene | 2476 | 350 (M+), 97 | 444 (M+), 173, 271 | 1.13 | 0.67 | 1.86 | 0.64 |
| 21 | 7-pentacosene | 2483 | 350 (M+), 97 | 444 (M+), 145, 299 | 0.48 | 0.27 | ||
| 22 | Pentacosane | 2500 | 352 (M+) | 0.56 | 0.37 | 0.07 | 0.04 | |
| 23 | Hexacosane | 2600 | 366 (M+) | 0.19 | 0.14 | tr | ||
| 24 | 4-methyl hexacosane | 2663 | 380 (M+), 365(M-15), 337 | 2.26 | 1.31 | 0.64 | 0.33 | |
| 25 | 9-heptacosene | 2677 | 378 (M+), 97 | 472 (M+), 173, 299 | 0.99 | 0.63 | tr | |
| 26 | 7-heptacosene | 2685 | 378 (M+), 97 | 472 (M+), 145, 327 | 3.91 | 2.32 | 0.12 | 0.07 |
| 27 | Heptacosane | 2700 | 380 (M+) | 1.09 | 0.74 | tr | ||
| 28 | 13-methyl heptacosane and 11-methyl heptacosane | 2730 | 379 (M-15), 196/197, 224/225 and 379 (M-15), 168/169, 252/253 | 0.22 | 0.08 | 0.03 | 0.01 | |
| 29 | 5-methyl heptacosane | 2748 | 379 (M-15), 337, 85 | 0.03 | 0.02 | 0.09 | 0.02 | |
| 30 | 4-methyl heptacosane | 2763 | 394 (M+), 379 (M-15), 351 | 0.17 | 0.05 | 0.12 | 0.07 | |
| 31 | Octacosane | 2800 | 394 (M+) | 0.40 | 0.07 | 0.18 | 0.16 | |
| 32 | x-methyl x-octacosene1 | 2832 | 406 (M+), 97 | 0.28 | 0.11 | 0.12 | 0.07 | |
| 33 | x,x-nonacosadiene1 | 2854 | 404 (M+), 96 | 0.37 | 0.21 | |||
| 34 | 4-methyl octocosane | 2862 | 408 (M+), 393 (M-15), 365 | 11.67 | 1.54 | 7.55 | 1.15 | |
| 35 | 9-nonacosene | 2877 | 406 (M+), 97 | 500 (M+), 173, 327 | 1.00 | 0.50 | 0.58 | 0.43 |
| 36 | 7-nonacosene | 2886 | 406 (M+), 97 | 500 (M+), 145, 355 | 1.71 | 1.01 | tr | |
| 37 | Nonacosane | 2900 | 408 (M+) | 1.02 | 0.55 | 1.07 | 1.23 | |
| 38 | 15-methyl nonacosane and 13-methyl nonacosane | 2926 | 407 (M-15), 224/225 & 407 (M-15), 196/197, 252/253 | 0.76 | 0.16 | 0.10 | 0.04 | |
| 39 | 5-methyl nonacosane | 2946 | 422 (M+), 407 (M-15), 85, 365 | 0.19 | 0.04 | 0.06 | 0.02 | |
| 40 | 4-methyl nonacosane | 2960 | 422 (M+), 407 (M-15), 379 | 0.68 | 0.12 | 0.44 | 0.15 | |
| 41 | 3-methyl nonacosane and 5,x-dimethyl nonacosane1 | 2973 | 422 (M+), 407 (M-15), 393 & 421 (M-15), 379 | 0.91 | 0.28 | 0.28 | 0.14 | |
| 42 | Triacontane | 3000 | 423(M+) | 0.30 | 0.16 | 0.09 | 0.06 | |
| 43 | x-methyl x-triacontene1 | 3028 | 434 (M+) | 0.84 | 0.26 | 0.24 | 0.13 | |
| 44 | x,x-hentriacosadiene1 | 3045 | 432 (M+), 96 | 1.85 | 0.60 | 0.19 | 0.12 | |
| 45 | x,x-hentriacosadiene1 | 3053 | 432 (M+), 96 | 0.23 | 0.10 | tr | ||
| 46 | 4-methyl triacontane | 3060 | 436 (M+), 421 (M-15), 393 | 19.63 | 2.40 | 14.25 | 5.08 | |
| 47 | 15-hentriacontene & 14-hentriacontene | 3064 | 434 (M+), 97 | 528 (M+), 257, 271 & 528 (M+), 243, 285 | 3.09 | 1.92 | ||
| 48 | 9-hentriacontene | 3078 | 434 (M+), 97 | 528 (M+), 173, 355 | 1.87 | 0.86 | 0.69 | 0.37 |
| 49 | x-hentriacontene1 (probably 7-hentriacontene) | 3087 | 434 (M+), 97 | 0.23 | 0.13 | |||
| 50 | Hentriacontane | 3100 | 436 (M+) | 0.54 | 0.34 | 0.21 | 0.10 | |
| 51 | unknown | 3110 | 0.05 | 0.04 | ||||
| 52 | unknown | 3117 | 0.12 | 0.08 | ||||
| 53 | 15-methyl hentriacontane & 13-methyl hentriacontane | 3125 | 435 (M-15), 224/225, 252/253 & 435 (M-15) 196/197, 280/281 | 2.69 | 1.08 | 0.79 | 0.35 | |
| 54 | 5-methyl hentriacontane | 3145 | 435 (M-15), 85, 393 | 0.23 | 0.10 | 0.24 | 0.12 | |
| 55 | 7,15-dimethyl hentriacontane | 3161 | 449 (M-15), 435 (M-30), 112/113, 252/253, 239, 379 | 1.25 | 0.42 | 0.72 | 0.35 | |
| 56 | 5,17-dimethyl hentriacontane | 3172 | 449 (M-15), 435 (M-30), 84/85, 224/225, 267, 407 | 2.32 | 1.16 | 0.84 | 0.58 | |
| 57 | unknown | 3191 | 0.15 | 0.07 | ||||
| 58 | Dotriacontane | 3200 | 450 (M+) | 0.38 | 0.25 | 0.18 | 0.11 | |
| 59 | x-methyl x-dotriacontene1 | 3227 | 462 (M+) | 0.68 | 0.23 | 0.32 | 0.20 | |
| 60 | x,x-tritriacontadiene1 | 3245 | 460 (M+), 96 | 2.43 | 0.59 | 2.74 | 0.74 | |
| 61 | x,x-tritriacontadiene1 | 3253 | 460 (M+), 96 | 0.76 | 0.14 | 3.48 | 1.07 | |
| 62 | 4-methyl dotriacontane | 3259 | 464 (M+), 449 (M-15), 421 | 3.10 | 0.39 | 1.50 | 0.60 | |
| 63 | 16-tritriacontene | 462 (M+), 97 | 556 (M+), 271, 285 | 2.46 | 0.66 | |||
| 64 | x-tritriacontene1 (probably 9-tritriacontene) | 3279 | 462 (M+), 97 | 0.78 | 0.43 | 0.41 | 0.11 | |
| 65 | x-tritriacontene1 (probably 7-tritriacontene) | 3287 | 462 (M+), 97 | 0.19 | 0.10 | tr | ||
| 66 | Tritriacontane | 3300 | 464 (M+) | 0.12 | 0.15 | |||
| 67 | x-methyl x-tetratriacontene1 | 3315 | 476 (M+), 97 | 570 (M+), 131, 439 (prob. 6-en) | 0.70 | 0.36 | ||
| 68 | 17-methyl tritriacontane & 15-methyl tritriacontane & 13-methyl tritriacontane | 3324 | 463 (M-15), 252/253 & 463 (M-15), 224/225, 280/281 & 463 (M-15), 196/197, 308/309 | 3.83 | 1.33 | 1.36 | 0.68 | |
| 69 | x,x-tetratriacontadiene1 | 3343 | 474 (M+), 96 | tr | 1.45 | 0.23 | ||
| 70 | x,x-dimethyl tritriacontane1 | 3357 | 57, 71, 85 | tr | 0.28 | 0.17 | ||
| 71 | 5,x-dimethyl tritriacontane1 | 3367 | 478 (M-15), 57, 71, 85, 436 | tr | 0.58 | 0.39 | ||
| 72 | Tetratriacontane | 3400 | 478 (M+) | tr | 0.10 | 0.06 | ||
| 73 | 9,19-pentatriacontadiene | 3443 | 488 (M+), 96 | 676 (M+), 173, 271, 311, 357, 409, 455, 535, 582 | 1.24 | 0.27 | 43.19 | 4.76 |
| 74 | x-pentatriacontene1 | 3480 | 490 (M+), 97 | 0.43 | 0.17 | |||
| 75 | x-methyl x-pentatriacontene1 | 3515 | 57, 97, 111 | 0.33 | 0.19 | |||
| 76 | 15-methyl pentatriacontane | 3521 | 491 (M-15), 224/225, 308/309 | 2.05 | 0.64 | 0.49 | 0.28 | |
| 77 | 7,15-dimethyl pentatriacontane | 3558 | 506 (M-15), 112/113, 239, 308/309, 435 | tr | 0.54 | 0.21 | ||
| 78 | 5,17-dimethyl pentatriacontane | 3569 | 506 (M-15), 84/85, 239, 308/309, 464 | tr | 0.30 | 0.20 | ||
| 79 | x,x-heptatriacontadiene1 | 3653 | 516 (M+), 96 | 1.22 | 0.52 |
1The position of the double bond(s) and/or the methyl group(s) could not be determined.
Figure 1Total ion current chromatograms (TIC) of an extract of L. clavipes (a) females and (b) males. Numbers above peaks correspond to Table 1. Only peaks representing more than 0.5% of the total peak area of all compounds are indicated. IS – internal standard (5 ng methyl decanoate).
Figure 2(a) Total duration of wing fanning behaviour and (b) number of wing fanning events shown by naïve virgin males of L. clavipes towards filter paper impregnated with the whole body extract of L. clavipes females, the hexane and DCM fractions thereof, the combined fractions, and the solvent control. Different letters indicate a significant difference (Kruskal Wallis ANOVA followed by pairwise Mann-Whitney U-Tests with Bonferroni-Holm correction, P < 0.05). For each experiment n = 20.
Figure 3Frequency of decision for sample or control of mated L. clavipes females in a y-tube experiment when choosing between the odour of (a) an unexploited host patch and a host patch with extract of L. clavipes females, (b) an unexploited host patch and a host patch with synthetic (−)-iridomyrmecin, (c) an unexploited host patch and a host patch with synthetic (+)-isoiridomyrmecin, and (d) synthetic (−)-iridomyrmecin and the solvent control. Bar colours indicate sample (dark blue) and control (unexploited host patch or the solvent, light blue). P-values are given for the two-sided binomial test. For each experiment n = 30.
Figure 4Illustration summarizing the response of males of L. heterotoma, L. boulardi, L. victoriae and L. clavipes to the defensive secretion (consisting of iridoid compounds) and the cuticular hydrocarbons (CHCs) of conspecific females.